Molecular Formula | C12H8Cl2N2O |
Molar Mass | 267.11 |
Solubility | ( < 1 mg/ml refers to the product slightly soluble or insoluble) |
Appearance | solid |
Color | White |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
Use | ICA 110381 (Compound 16) is a KCNQ2/Q3 potassium channel opener for the treatment of epilepsy. ICA 110381 is a KCNQ2/Q3 agonist with EC50 of 0.38 μM and KCNQ1 antagonist with IC50 of 15 μM, respectively. |
Target | KCNQ2/Q3; KCNQ1 |
Reference Show more | 1. Amato G , Roeloffs R , Rigdon G C , et al. N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy[J]. ACS Medicinal Chemistry Letters, 2011, 2(6):481. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.744 ml | 18.719 ml | 37.438 ml |
5 mM | 0.749 ml | 3.744 ml | 7.488 ml |
10 mM | 0.374 ml | 1.872 ml | 3.744 ml |
5 mM | 0.075 ml | 0.374 ml | 0.749 ml |
biological activity | ICA 110381 (Compound 16) is a opener for the KCNQ2/Q3 silicone channel for the treatment of epilepsy. ICA 110381 exhibited agonist activity against KCNQ2/Q3 with an EC50 value of 0.38 μm and antagonist activity against KCNQ1 with an IC50 value of 15 μm. |
Target | Value |
KCNQ2/Q3 (Cell-free assay) | 0.38 μM(EC50) |
KCNQ1 (Cell-free assay) | 15 μM |